U.S. Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage (Adults, Pediatrics), By Indication (Cancer Care, Diabetes), By End use (Hospitals, Home Care), By Sales Channel, And Segment Forecasts, 2025 - 20

Market Size & Trends

The U.S. enteral feeding formulas market size was estimated at USD 2.06 billion in 2024 and is projected to grow at a CAGR of 5.7% from 2025 to 2030. The increasing prevalence of chronic diseases, including cancer, stroke, multiple sclerosis, dementia, chronic liver disease, chronic obstructive pulmonary disease (COPD), and diabetes, is anticipated to increase the demand for products addressing oral intake challenges. The Centers for Disease Control and Prevention (CDC) reports published in May 2024 states that approximately 38.4 million people in U.S. have diabetes, which is around 11.96% of the overall population.

The growing prevalence of Alzheimer’s disease is boosting demand for enteral feeding formulas, as patients in advanced stages often face difficulty in swallowing and require nutritional support. According to the CDC, around 6.9 million people in the U.S. are living with Alzheimer’s disease. Furthermore, in 2022, it was the 7th leading cause of death among U.S. adults and the 6th leading cause of death among adults 65 years or older. The rising aging population in the U.S. is another key factor driving the demand for enteral feeding formulas. As individuals age, they often experience physiological changes such as reduced appetite, swallowing difficulties (dysphagia), and decreased digestive efficiency, leading to malnutrition if not properly managed. Enteral feeding provides a practical solution to ensure adequate nutrient intake among elderly individuals, particularly those residing in assisted living or long-term care facilities.

Increased awareness among caregivers and healthcare providers regarding the importance of early nutritional intervention in geriatric care is further fueling the adoption of enteral nutrition products.

Rise in preterm births is one of the significant factors boosting the demand for sip feeds to meet the nutritional requirements of newborns. According to the CDC in 2022, preterm birth affected about 1 of every 10 infants born in the U.S. In addition, the continued rise in nutritional and other deficiencies, including severe deficiency of micronutrients, proteins, and other nutrients, especially in infants and pregnant women, is leading to an increase in the demand for enteral feeding formulas.

U.S. Enteral Feeding Formulas Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. enteral feeding formulas market report based on product, flow type, stage, indication, end use, and sales channel.

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Standard Formula
• Disease-specific Formulas
• Flow Type Outlook (Revenue, USD Million, 2018 - 2030)
• Intermittent Feeding Flow
• Continuous Feeding Flow
• Stage Outlook (Revenue, USD Million, 2018 - 2030)
• Adults
• Pediatrics
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Alzheimer’s
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Cardiology
• Neurology
• Critical Care (ICU)
• Oncology
• Others
• Home Care
• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Online Sales
• Retail Sales
• Institutional Sales